Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Informe acción SGX:T14

Capitalización de mercado: US$2.9b

Tianjin Pharmaceutical Da Ren Tang Group Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Lei Wang

Chief Executive Officer (CEO)

CN¥2.6m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.1yrs
Participación del CEOn/a
Permanencia media de la dirección2.3yrs
Promedio de permanencia en la Junta Directiva2.8yrs

Actualizaciones recientes de la dirección

Recent updates

Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?

Nov 03
Is Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) A Risky Investment?

Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value

Aug 08
Is Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14) Expensive For A Reason? A Look At Its Intrinsic Value

Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?

Jul 21
Should You Be Adding Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) To Your Watchlist Today?

We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease

Jun 20
We Think Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Can Manage Its Debt With Ease

If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity

Apr 17
If EPS Growth Is Important To You, Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Presents An Opportunity

Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

Mar 01
Calculating The Intrinsic Value Of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)

Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet

Feb 03
Tianjin Pharmaceutical Da Ren Tang Group (SGX:T14) Has A Pretty Healthy Balance Sheet

CEO

Lei Wang (53 yo)

2.1yrs

Permanencia

CN¥2,625,100

Compensación

Ms. Lei Wang serves as Executive Director of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited since December 30, 2022 and serves as its General Manager since August 22, 2022. She served as Gene...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Lei Wang
GM & Executive Director2.1yrsCN¥2.63msin datos
Jian Ma
Chief Financial Officer1.2yrsCN¥190.30ksin datos
Hong Zhou
Deputy GM5.3yrsCN¥1.38m0.0031%
CN¥ 91.1k
Min Guo
Executive Directorno datasin datossin datos
Yu Zhang
Chief Manufacturing Officer2.4yrsCN¥893.80ksin datos
Mingjie Shang
Executive Directorless than a yearCN¥299.00ksin datos
Yan Jiao
Secretary to the Board of Directors16.8yrsCN¥445.80k0.0013%
CN¥ 38.9k

2.3yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de T14 se considera experimentado (2 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lei Wang
GM & Executive Director1.8yrsCN¥2.63msin datos
Hong Zhou
Deputy GM5.3yrsCN¥1.38m0.0031%
CN¥ 91.1k
Min Guo
Executive Director3.2yrssin datossin datos
Mingjie Shang
Executive Director1.3yrsCN¥299.00ksin datos
Yoke Pheng Liew
Independent & Non-Executive Director4.3yrsCN¥259.16ksin datos
Yuanxia Wang
Chairman of Board of Supervisors4.8yrssin datossin datos
Jianhua Xing
Supervisor2.8yrssin datossin datos
Mingrui Zhang
Non-Executive & Non-Independent Chairman2.8yrssin datossin datos
Weiwen Mao
Non-Executive Non-Independent Director1.8yrssin datossin datos
Guat Kwang Yeo
Lead Independent Directorless than a yearsin datossin datos
Ming Zhong
Independent Directorless than a yearsin datossin datos

2.8yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de T14 no se considera experimentada (2.5 años de permanencia promedio), lo que sugiere una nueva junta directiva.